SE7510812L - Sett att framstella ett nukleasresistent hydrofilt komplex av polyriboinosin-polyribocytidyl-syra - Google Patents

Sett att framstella ett nukleasresistent hydrofilt komplex av polyriboinosin-polyribocytidyl-syra

Info

Publication number
SE7510812L
SE7510812L SE7510812A SE7510812A SE7510812L SE 7510812 L SE7510812 L SE 7510812L SE 7510812 A SE7510812 A SE 7510812A SE 7510812 A SE7510812 A SE 7510812A SE 7510812 L SE7510812 L SE 7510812L
Authority
SE
Sweden
Prior art keywords
polyriboinosin
polyribocytidyl
hydrofile
nucleas
resistant
Prior art date
Application number
SE7510812A
Other languages
English (en)
Other versions
SE403783B (sv
Inventor
H B Levy
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Publication of SE7510812L publication Critical patent/SE7510812L/sv
Publication of SE403783B publication Critical patent/SE403783B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Saccharide Compounds (AREA)
SE7510812A 1974-09-27 1975-09-26 Sett att framstella ett nukleasresistent hydrofilt komplex av polyrboinosin-polyribocytidylsyra, poly-l-lysin och karboximetylcellulosa med interferoninducerande egenskaper SE403783B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/509,966 US3952097A (en) 1974-09-27 1974-09-27 Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid

Publications (2)

Publication Number Publication Date
SE7510812L true SE7510812L (sv) 1976-03-29
SE403783B SE403783B (sv) 1978-09-04

Family

ID=24028821

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7510812A SE403783B (sv) 1974-09-27 1975-09-26 Sett att framstella ett nukleasresistent hydrofilt komplex av polyrboinosin-polyribocytidylsyra, poly-l-lysin och karboximetylcellulosa med interferoninducerande egenskaper

Country Status (13)

Country Link
US (1) US3952097A (sv)
JP (1) JPS5186484A (sv)
BE (1) BE833838A (sv)
CA (2) CA1038375A (sv)
CH (1) CH616432A5 (sv)
DE (1) DE2543214A1 (sv)
FR (1) FR2285893A1 (sv)
GB (1) GB1488209A (sv)
HU (1) HU174918B (sv)
IL (1) IL48099A (sv)
NL (1) NL7511370A (sv)
SE (1) SE403783B (sv)
ZA (1) ZA755865B (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024241A (en) * 1974-09-27 1977-05-17 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
US4388306A (en) * 1980-06-04 1983-06-14 Merck & Co., Inc. Pharmaceutical composition comprising modified polyriboinosinic-polyribocytidylic acid, for induction of interferon in primates
US4389395A (en) * 1981-01-09 1983-06-21 Lerner A Martin Low molecular weight complex of polyriboinosinic-polyribocytidylic acid and method of inducing interferon
US7229822B1 (en) * 2000-02-29 2007-06-12 Univ Columbia Melanoma differentation associated gene-5 and vectors and cells containing same
DK1898948T3 (da) * 2005-06-08 2012-04-23 Yisheng Biopharma Singapore Pte Ltd Polyriboinosinsyre-polyribocytidylsyre-baseret adjuvans
US20070166239A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
US20070166800A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
US20090041809A1 (en) * 2007-03-07 2009-02-12 Nventa Biopharmaceuticals Corporation Double-stranded locked nucleic acid compositions
CA2735724C (en) 2008-06-19 2018-07-24 Variation Biotechnologies Inc. Compositions and methods for treating influenza
US20110097418A1 (en) * 2009-05-29 2011-04-28 Variation Biotechnologies, Inc. Compositions and methods for treating influenza
US9907746B2 (en) 2009-07-06 2018-03-06 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
MX2012000372A (es) 2009-07-06 2012-02-28 Variation Biotechnologies Inc Metodos para preparar vesiculas y formulaciones producidas a partir de las mismas.
JP6119030B2 (ja) 2010-07-06 2017-04-26 ヴァリエーション バイオテクノロジーズ インコーポレイテッド インフルエンザを治療するための組成物及び方法
EP2663327A4 (en) 2011-01-13 2015-12-02 Variation Biotechnologies Inc COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
US20130323280A1 (en) 2011-01-13 2013-12-05 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
AU2013208693B2 (en) 2012-01-12 2017-12-07 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
CA2894467A1 (en) 2012-01-27 2013-08-01 Variation Biotechnologies Inc. Methods for preparing thermostable compositions comprising a lipid component and thermolabile therapeutic agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2851453A (en) * 1954-08-09 1958-09-09 Smith Kline French Lab Cellulose derivative product, compositions comprising the same and their preparation
US3066075A (en) * 1960-07-25 1962-11-27 G W Carnrick Co Compositions comprising amphetamine and carboxymethyl cellulose in chemically combined form
US3493559A (en) * 1967-05-29 1970-02-03 Upjohn Co 2-thiocytosine ribofuranosides
BE757291A (fr) * 1969-10-10 1971-04-09 Smith Kline French Lab Complexe antiviral de arn et d'un polysaccharide
GB1364987A (en) * 1971-06-19 1974-08-29 Merck Patent Gmbh Biologically active two component complexes
BE790953A (fr) * 1971-11-05 1973-05-03 Beecham Group Ltd Matiere biologiquement active
US3853846A (en) * 1973-02-12 1974-12-10 Abbott Lab INOSINE-5 -Carboxylates

Also Published As

Publication number Publication date
CA1038375A (en) 1978-09-12
SE403783B (sv) 1978-09-04
NL7511370A (nl) 1976-03-30
ZA755865B (en) 1976-08-25
HU174918B (hu) 1980-04-28
CH616432A5 (sv) 1980-03-31
JPS5186484A (en) 1976-07-29
IL48099A (en) 1978-04-30
IL48099A0 (en) 1975-11-25
FR2285893B1 (sv) 1980-08-08
DE2543214A1 (de) 1976-05-20
FR2285893A1 (fr) 1976-04-23
US3952097A (en) 1976-04-20
BE833838A (fr) 1976-01-16
GB1488209A (en) 1977-10-12
CA1091648B (en) 1980-12-16

Similar Documents

Publication Publication Date Title
SE420405B (sv) Sett att framstella ett polykarboxylatcement
CS179938B2 (en) Method for production of n-phosphonomethyl-glycine
SE7510812L (sv) Sett att framstella ett nukleasresistent hydrofilt komplex av polyriboinosin-polyribocytidyl-syra
SE7513990L (sv) Sett att framstella 3-amino-indiazolkarbonsyra-derivat
SE7513708L (sv) Forfarande for framstellning av ett 2-dekarboxi-2-(tetrazol-5-yl)-11-desoxi-15-substituerade omega-petanorprostaglandiner
SE404804B (sv) Sett att framstella 18-metyl-19-nor-20-ketopregnaner
SE426171B (sv) Forfarande for framstellning av d-(-)-alfa-amino-alfa-(p-acyloxifenyl) acetamidocefalosporansyror
SE7507723L (sv) Forfarande for framstellning av fosforsyra
SE422800B (sv) Forfarande for framstellning av 6-d-(-)-alfa-amino-alfa(p-acetoxifenylacetamido) penicillansyra
SE405254B (sv) Sett att framstella 7-hydroxi-ostratriener
SE404528B (sv) Sett att framstella 1alfa-hydroxisteroider
SE7608206L (sv) Forfarande for framstellning av ett rabiesvaccin
SE404360B (sv) Sett att framstella 2-nitrobensaldehyd
SE405525B (sv) Sett att framstella ett halvledaraggregat
SE431983B (sv) Sett att framstella 15-etylendioxiprostansyraderivat
SE411447B (sv) Sett att framstella 4-cyklopropylmetylenoxi- 3-klorfenylettiksyra
SE402458B (sv) Sett att framstella nya 2-amino-6-dialkylamino-dihydropyridiner
SE7508779L (sv) Sett att framstella prostaninsyraderivat
SE7503607L (sv) Forfarande for framstellning av en foregangsform av teofyllin.
SE412534B (sv) Forfarande for framstellning av ett gangjern
SE7513234L (sv) Sett att framstella en vanadinkatalysator
SE7504060L (sv) Av ett vikbart emne tillverkad forpackning
SE384365B (sv) Sett att framstella ett farmaceutiskt anvendbart kalciumsalt av 6-acetyl-amino-hexansyra
SE7804075L (sv) Forfarande for framstellning av ett nytt antibiotikum
SE7510932L (sv) Sett att framstella 2-hydroximetyl-tiazol-5-karboxylsyraderivat